We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Alliance to Develop vCJD Blood Test

By HospiMedica staff writers
Posted on 18 Dec 2001
An exclusive agreement to develop a human blood test for variant Creutzfeldt-Jacob disease (vCJD) has been announced by Ortho-Clinical Diagnostics, Inc. More...
(OCD, Raritan, NJ, USA) and Caprion Pharmaceuticals Inc. (Montreal, Canada). Currently, no diagnostic test exists to screen for vCJD in the blood supply, according to the two companies.

The arrangement is an extension of an earlier research collaboration, where OCD exercised an option to license Caprion's prion technologies, including unique monoclonal antibodies for the detection of the agent responsible for vCJD. Caprion employs a proprietary, integrated subcellular proteomics discovery platform and expertise in cell fractionation to create comprehensive intracellular maps identifying the location, orientation, and movement of human proteins. OCD has obtained worldwide exclusive rights to the test for the marketing and distribution of human in vitro diagnostic applications and will fund all development activities and regulatory expenses.

"Health-care agencies worldwide are striving to ensure that blood supplies are safe, and the development of a test for vCJD would allow them to do so,” said Catherine M. Burzik, president of OCD.




Related Links:
Caprion
Ortho

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.